UK markets closed

Avidity Biosciences, Inc. (RNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
26.45+0.87 (+3.40%)
At close: 04:00PM EDT
27.00 +0.55 (+2.08%)
After hours: 07:35PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
185,082
340,396
320,448
321,462
Other short-term investments
410,269
270,331
85,095
6,679
Total cash
595,351
610,727
405,543
328,141
Net receivables
1,105
2,364
-
-
Other current assets
-
12,215
5,598
3,537
Total current assets
611,307
622,942
411,141
331,678
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
21,873
18,129
17,322
3,901
Accumulated depreciation
-5,221
-3,120
-1,733
-1,979
Net property, plant and equipment
16,652
15,009
15,589
1,922
Other long-term assets
596
849
850
298
Total non-current assets
17,248
15,858
16,439
2,220
Total assets
628,555
638,800
427,580
333,898
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
8,809
4,637
2,806
-
Accrued liabilities
25,532
27,935
11,279
-
Deferred revenues
28,365
5,041
4,864
3,690
Total current liabilities
80,680
51,908
29,658
14,587
Non-current liabilities
Deferred revenues
40,898
1,235
6,532
12,150
Total non-current liabilities
47,111
8,817
16,492
13,088
Total liabilities
127,791
60,725
46,150
27,675
Stockholders' equity
Common stock
8
7
5
4
Retained earnings
-570,764
-358,544
-184,549
-66,540
Accumulated other comprehensive income
125
-2,698
-187
-5
Total stockholders' equity
500,764
578,075
381,430
306,223
Total liabilities and stockholders' equity
628,555
638,800
427,580
333,898